THERAPY: Risk of metformin use in patients with T2DM and advanced CKD

    loading  Checking for direct PDF access through Ovid

Abstract

In a new study published inThe Lancet Diabetes & Endocrinology, metformin use is associated with significantly increased all-cause mortality in patients with type 2 diabetes mellitus and stage 5 chronic kidney disease (CKD). The findings support current recommendations that metformin should not be used in patients with stage 5 CKD.

Related Topics

    loading  Loading Related Articles